Open access · OA
via OpenAlex
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Katri Heikkinen, Katrin Rapakko, Sanna-Maria Karppinen, Hannele Erkko, Sakari Knuutila, Tuija Lundán, Arto Mannermaa, Anne-Lise Børresen-Dale, Ake Borg, Rosa B Barkardottir, John Petrini, Robert Winqvist
Carcinogenesis · 2005 · ▲ 213 citations
Abstract
The Mre11 complex, composed of RAD50, NBS1 and MRE11, has an essential role in the maintenance of genomic integrity and preventing cells from malignancy. Here we report the association of three Mre11 complex mutations with hereditary breast cancer susceptibility, studied by using a case-control design with 317 consecutive, newly diagnosed Northern Finnish breast cancer patients and 1000 geographically matched healthy controls (P = 0.0004). RAD50 687delT displayed significantly elevated frequency in the studied patients (8 out of 317, OR 4.3, 95% CI 1.5-12.5, P= 0.008), which indicates that it is a relatively common low-penetrance risk allele in this cohort. Haplotype analysis and the screening of altogether 512 additional breast cancer cases from Sweden, Norway and Iceland suggest that RAD50 687delT is a Finnish founder mutation, not present in the other Nordic cohorts. The RAD50 IVS3-1G>A splicing mutation leading to translational frameshift was observed in one patient, and the NBS1 Leu150Phe missense mutation affecting a conserved residue in the functionally important BRCA1 carboxy-terminal (BRCT) domain in two patients, both being absent from 1000 controls. Microsatellite marker analysis showed that loss of the wild-type allele was not involved in the tumorigenesis in any of the studied mutation carriers, but they all showed increased genomic instability assessed by cytogenetic analysis of peripheral blood T-lymphocytes (P = 0.006). In particular, the total number of chromosomal rearrangements was significantly increased (P = 0.002). These findings suggest an effect for RAD50 and NBS1 haploinsufficiency on genomic integrity and susceptibility to cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/carcin/bgi360
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Heikkinen, K., Rapakko, K., Karppinen, S., Erkko, H., Knuutila, S., Lundán, T., Mannermaa, A., Børresen-Dale, A., Borg, A., Barkardottir, R.B., Petrini, J., & Winqvist, R. (2005). RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. <em>Carcinogenesis</em>. https://doi.org/10.1093/carcin/bgi360
Vancouver
Heikkinen K, Rapakko K, Karppinen S, Erkko H, Knuutila S, Lundán T, et al. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis. 2005. doi:10.1093/carcin/bgi360.
BibTeX
@article{katri2005RADand,
title = {RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability},
author = {Katri Heikkinen and Katrin Rapakko and Sanna-Maria Karppinen and Hannele Erkko and Sakari Knuutila and Tuija Lundán and Arto Mannermaa and Anne-Lise Børresen-Dale and Ake Borg and Rosa B Barkardottir and John Petrini and Robert Winqvist},
journal = {Carcinogenesis},
year = {2005},
doi = {10.1093/carcin/bgi360},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular and Cellular Biology 2017
Open access · OA
DNA Damage Response-Independent Role for MDC1 in Maintaining Genomic Stability
Journal of Taibah University Medical Sciences 2026
Open access · OA
Evolutionary study of oncogenes and tumor suppressor genes in breast carcinoma.
Nature Genetics 2019
Preprint · OA
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
The Journal of Cell Biology 2017
Open access · CC-BY
Pathways of cellular proteostasis in aging and disease
Nutrients 2021
Open access · CC-BY
Comparative Analysis of the Impact of Urolithins on the Composition of the Gut Microbiota in Normal-Diet Fed Rats
Clinical Cancer Research 2006
Open access · OA